Proteomics Intl Labs Ltd has released a press release.
US patent for identifying drugs for abnormal kidney function
Filed with ASX ·
6ix hasn’t read this filing yet.
Proteomics International Laboratories Ltd. on 6ix
Story so far
Earlier from Proteomics International Laboratories
- Appendix 4C - December 2018 Quarterly Report
- PromarkerD US market update
- Proteomics signs PromarkerD agreement with US big pharma
- PromarkerD kit version complete- commercial release imminent
- Appendix 4C - September 2018 Quarterly Report
Later from Proteomics International Laboratories
- Appendix 4C - March 2019 Quarterly Report
- Proteomics secures contracts for pharmacokinetic analysis
- Appendix 4C - June 2019 Quarterly Report
- PromarkerD test ready for launch in Europe
- PromarkerD diabetic kidney disease test launched in Spain
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories